Antibody–Drug Conjugates in NSCLC: Complexities, Challenges, and Potential

Luis E. Raez, MD

2019 IASLC World Conference on Lung Cancer Updates

GLCC and IASLC Form Partnership to Explore Progress in Lung Cancer Treatment

Consolidating Gains with Chemotherapy in SCLC Maintenance Trials: A Discussion with Dr. Shirish Gadgeel

Ireland’s Complex Healthcare System and Its Relation to Innovative Ways for Patients to Access Trials

Tackling TKI-Refractory Disease in Patients with Oncogenic Drivers: An Interview with Dr. Mark Socinski

Making Headway with Lorlatinib

Clinical Utility of Plasma Next-Generation Sequencing in Advanced NSCLC: Are We Ready for a ‘Blood-First’ Approach?

Korean Lung Cancer Screening Project (K-LUCAS) Led to Launch of New National Lung Cancer Screening Program in Korea

Letter to the Editor: Previously Excluded Patients with Autoimmune Disorders, HIV, and More

KEYNOTE-010: Long-Term Outcomes and Results of Retreatment